Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation
20.38 +0.31 (1.54%)
- Market Cap
- $1.19B
- Volume
- 1.57M
- Dividend yield
- n/a
- Next earnings date
- Nov 4, 2026
PROCEPT BioRobotics Corporation (PRCT) Stock Price, Analysis & Data
Intrinsic Value
Analyst Forecast
Stock Forecasts →Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | $94.50M | n/a | +19.34% |
| EPS | -$0,47 | -$0,02 | -34.29% |
Metrics
- Bid
- 13.9
- Market Cap
- 1.19B
- Revenue (ttm)
- 337M
- Net Income (ttm)
- -110M
- 0.90
- -1.95
- n/a
- -18.15
- P/B (ttm)
- 3.52
- P/S (ttm)
- 3.55
- Earnings Date
- Nov 4, 2026
- Ask
- 22.04
- Volume
- 1,573,244
- Avg. Volume (20D)
- 1,582,977
- Open
- 20.53
- Previous Close
- 20.07
- Day's Range
- 19.55 - 20.67
- 52-Week Range
- 16.66 - 40.10
- Analyst
- n/a
- Price Target
- n/a
- Dividends
- n/a
- Ex-Dividend Date
- n/a
About PROCEPT BioRobotics Corporation
View profile →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Industry Medical Devices
Sector Healthcare
IPO Date Sep 15, 2021
Employees 888
Stock Exchange NasdaqGM
Ticker Symbol PRCT